<?xml version="1.0" encoding="UTF-8"?>
<p>Immunomodulators may both stimulate or suppress the immune system by inhibiting and/or increasing the synthesis and release of pro-inflammatory mediators, including cytokines and eicosanoids. There is preclinical evidence of increased IL-1B and/or IL-18 production in infected immune cells by the use of 
 <italic>Sambucus nigra</italic> L., polysaccharide-rich extracts from medicinal mushrooms, 
 <italic>Echinacea angustifolia</italic> DC. and 
 <italic>Echinacea purpurea</italic> L. (Moench.), Larch (
 <italic>Larix</italic> sp.) arabinogalactans-rich extracts, and plant extracts or food supplements rich in Vitamin D (
 <xref rid="B21" ref-type="bibr">Alschuler et al., 2020</xref>).
</p>
